rs200639270
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_000159.4(GCDH):c.395G>A(p.Arg132Gln) variant causes a missense change. The variant allele was found at a frequency of 0.00000929 in 1,613,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R132G) has been classified as Uncertain significance.
Frequency
Consequence
NM_000159.4 missense
Scores
Clinical Significance
Conservation
Publications
- glutaryl-CoA dehydrogenase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GCDH | NM_000159.4 | c.395G>A | p.Arg132Gln | missense_variant | Exon 6 of 12 | ENST00000222214.10 | NP_000150.1 | |
| GCDH | NM_013976.5 | c.395G>A | p.Arg132Gln | missense_variant | Exon 6 of 12 | NP_039663.1 | ||
| GCDH | NR_102316.1 | n.558G>A | non_coding_transcript_exon_variant | Exon 6 of 12 | ||||
| GCDH | NR_102317.1 | n.811G>A | non_coding_transcript_exon_variant | Exon 5 of 11 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GCDH | ENST00000222214.10 | c.395G>A | p.Arg132Gln | missense_variant | Exon 6 of 12 | 1 | NM_000159.4 | ENSP00000222214.4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152098Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461610Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727138 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152216Hom.: 0 Cov.: 31 AF XY: 0.0000134 AC XY: 1AN XY: 74418 show subpopulations
ClinVar
Submissions by phenotype
Glutaric aciduria, type 1 Pathogenic:6
- -
- -
- -
PM2_Supporting+PP3_Strong+PM3_VeryStrong -
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 132 of the GCDH protein (p.Arg132Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with glutaryl-CoA dehydrogenase deficiency (PMID: 10699052, 10960496, 24332224, 34344405; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 377917). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GCDH protein function. For these reasons, this variant has been classified as Pathogenic. -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
not provided Pathogenic:1
The R132Q variant in the GCDH gene has previously been reported in association with GA1 in several unrelated individuals (Zschocke et al., 2000; Busquets et al., 2000; Wang et al., 2013). The R132Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. Additionally, this substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, we interpret R132Q to be a pathogenic variant. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at